Platelet-type 12-lipoxygenase accelerates tumor promotion of mouse epidermal cells through enhancement of cloning efficiency

Carcinogenesis

Volumn 29, Issue 2, 2008, Pages 440-447

  Piao, Ying Shi ^a,b   Du, Yu Chen ^a   Oshima, Hiroko ^a   Jin, Jing Chun ^b   Nomura, Masaaki ^c   Yoshimoto, Tanihiro ^a   Oshima, Masanobu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b YANBIAN UNIVERSITY   (China)

^c HOKURIKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; BAICALEIN; CYTOKINE; HYDROXYICOSATETRAENOIC ACID; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL CLONING; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDERMIS CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; THROMBOCYTE; TUMOR GROWTH; TUMOR PROMOTION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BLOOD PLATELETS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; ENZYME INHIBITORS; EPIDERMIS; EPITHELIAL CELLS; FLAVANONES; MICE; MICE, INBRED BALB C; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40549104132     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm274     Document Type: Article

References (39)

1. Shureiqi,I. et al. (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res., 61, 6307-6312.
2. DuBois,R.N. et al. (1998) Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
3. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
4. Oshima,H. et al. (2004) Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J., 23, 1669-1678.
5. 2 pathway. Gastroenterology, 131, 1086-1095.
6. Furstenberger,G. et al. (2006) What are cyclooxygenase and lipoxygenase doing in the driver's seat of carcinogenesis? Int. J. Cancer, 119, 2247-2254.
7. Tang,K. et al. (1999) 12(S)-HETE in cancer metastasis. Adv. Exp. Med. Biol., 447, 181-191.
8. Yoshimoto,T. et al. (2002) Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Mediat., 68-69, 245-262.
9. Chen,Y.Q. et al. (1994) Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res., 54, 1574-1579.
10. Gao,X. et al. (1995) Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology, 46, 227-237.
11. Timar,J. et al. (2000) Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell line of different metastatic potential. Int. J. Cancer 87, 37-43.
12. Wong,B.C. et al. (2001) 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis, 22, 1349-1354.
13. Raso,E. et al. (2004) Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions. Melanoma Res., 14 245-250.
14. Krieg,P. et al. (1995) 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol. Carcinog., 14, 118-129.
15. Tong,W.G. et al. (2002) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol. Cancer Ther., 1, 929-935.
16. Tong,W.G. et al. (2002) The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells. Biochem. Biophys. Res. Commun., 296, 942-948.
17. Leung,H.W.C. et al. (2007) Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem. Toxicol., 45, 403-411.
18. Ding,X.Z. et al. (2001) 12-Lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation. Int. J. Cancer, 94 630-636.
19. 5 integrin expression. Cancer Res., 63, 4258-4267.
20. Nie,D. et al. (2003) Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clin. Exp. Metastasis, 20, 657-663.
21. Nie,D. et al. (2006) Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells. J. Biol. Chem., 281 18601-18609.
22. McCabe,N.P. et al. (2006) Vascular endothelial growth factor production in human prostate cancer cells in stimulated by overexpression of platelet 12-lipoxygenase. Prostate, 66, 779-787.
23. Virmani,J. et al. (2001) Role of 'platelet-type' 12-lipoxygenase in skin carcinogenesis. Cancer Lett., 162, 161-165.
24. Colburn,N.H. et al. (1982) Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells. Cancer Res., 42, 3093-3097.
25. Bernstein,L.R. et al. (1989) AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244, 566-569.
26. Oshima,M. et al. (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl Acad. Sci. USA, 92, 4482-4486.
27. Miocinovic,R. et al. (2005) In vivo and in vitro effect of baicalein on human prostate cancer cells. Int. J. Oncol. 26, 241-246.
28. Deschamps,J.D. et al. (2006) Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenase. Bioorg. Med Chem., 14, 4295-4301.
29. Hsu,T.C. et al. (2001) Transformation non-responsive cells owe their resistance to lack of p65/NF-κB activation. Cancer Res., 61, 4160-4168.
30. Hu,J. et al. (2004) Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis, 25, 1991-2003.
31. Dhar,A. et al. (2002) The role of AP-1, NF-κB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Mol. Cell. Biochem., 234/235, 185-193.
32. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
33. Greten,F.R. et al. (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
34. Pikarsky,E. et al. (2004) NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature, 431, 461-466.
35. Lovat,P.E. et al. (2002) GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma. Cancer Res., 62 5158-5167.
36. Δ716 knockout mice. Nat. Med., 7, 1048-1051.
37. Oshima,M. et al. (2002) COX selectivity and animal models for colon cancer. Curr. Pharm. Des., 8, 1021-1034.
38. Tan,W. et al. (2007) Association of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis, 28, 1197-1201.
39. Shappell,S.B. et al. (2003) Elevated expression of 12/ 15-lipoxygenase and cylclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res., 63, 2256-2267.